| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.10.24 | CAPINFO (01075): CHANGE OF H SHARES REGISTRAR AND TRANSFER OFFICE IN HONG KONG | ||
| 27.09.24 | CAPINFO (01075): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | ||
| 27.09.24 | CAPINFO (01075): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | ||
| 19.09.24 | CAPINFO (01075): 2024 INTERIM REPORT | ||
| 12.09.24 | CAPINFO (01075): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 31.10.24 | Kyoto Group AS: Second European Heatcube installation at KALL Ingredients nears completion | OSLO, Norway, Oct. 31, 2024 /PRNewswire/ -- Kyoto Group is thrilled to announce rapid progress on our second European Heatcube installation at KALL Ingredients in Hungary. This milestone... ► Artikel lesen | |
| 11.10.24 | KYOTO GROUP AS: Kyoto Group supports Norway's bold move to ban fossil fuels from Industrial Heat processes | ||
| 02.08.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.08.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 02.08.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.08.2024.ISIN NameAU000000ALU8 ALTIUM... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.02. | TC BioPharm: TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial | No adverse events related to TCB008 have occurred
Evidence of stable disease following TCB008 infusion
EDINBURGH, Scotland, Feb. 13, 2025 /PRNewswire/ --... ► Artikel lesen | |
| 10.02. | TC BioPharm plc - 6-K, Report of foreign issuer | ||
| 10.02. | TC BioPharm vermeldet Fortschritte bei AML-Behandlungsstudie | ||
| 10.02. | TC BioPharm: TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial | First Cohort B patient received 4 doses (approx. 819 million Gamma Delta T-cells)
Cohort B recruitment continues at multiple clinical sites across the United... ► Artikel lesen | |
| 10.02. | EXCLUSIVE: Nano-Cap TC BioPharm Concludes Initial Cohort B Patient Dosing In Mid-Stage Leukemia Trial, Data Readout By End Of 2025 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.02. | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer | ||
| 30.12.24 | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer | ||
| 29.11.24 | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer | ||
| 15.11.24 | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer | ||
| 31.10.24 | XYLO TECHNOLOGIES LTD - 6-K, Report of foreign issuer |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| CAPINFO CO LTD | 0,232 | -0,85 % |
| KYOTO GROUP AS | 1,880 | 0,00 % |
| TC BIOPHARM HOLDINGS PLC ADR | 2,490 | -1,78 % |
| XYLO TECHNOLOGIES LTD ADR | 3,900 | -20,41 % |
